Sitemap
May 30, 2020 Articles
Filter by Available Specialty
- Adjuvant pembrolizumab confers durable RFS benefit in resected stage III melanoma
- AGA announces awardees to receive research funding
- Anthracycline chemotherapy shows no benefit in HER2-positive breast cancer
- AST president: COVID-19 provides opportunity for collaboration
- Black patients with COVID-19 account for majority of hospitalizations, deaths in Louisiana cohort
- CAR T-cell therapy could ‘revolutionize’ treatment of advanced multiple myeloma
- Cost-effective drug found to prevent hepatitis C transmission in kidney transplantation
- HER2-targeted therapy shows antitumor activity in metastatic colorectal cancer
- How technology and COVID-19 have revolutionized telepsychiatry
- Legislation requiring plain language summaries may increase trust in pharma industry
- Medtronic launches directional cannula for balloon kyphoplasty procedures
- Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
- NCI director: COVID-19 having ‘profound’ effects on cancer outcomes, research
- Pyrotinib-capecitabine combination improves outcomes in breast cancer subset
- Ramucirumab-gemcitabine combination confers OS benefit in malignant pleural mesothelioma
- SCAI news: REDUCE-IT, fasting before catheterization, telehealth and more
- Tucatinib combination extends OS in HER2-positive breast cancer with brain metastases
- VIDEO: Khanani delves into data from OPTIC trial